| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42858-134-01 | 42858-134 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | CAPSULE | ORAL | 20170601 | N/A | ANDA | ANDA075753 | Rhodes Pharmaceuticals L.P. | FENOFIBRATE | 134 mg/1 | 100 CAPSULE in 1 BOTTLE (42858-134-01) |
| 42858-200-01 | 42858-200 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | CAPSULE | ORAL | 20170601 | N/A | ANDA | ANDA075753 | Rhodes Pharmaceuticals L.P. | FENOFIBRATE | 200 mg/1 | 100 CAPSULE in 1 BOTTLE (42858-200-01) |
| 42858-067-01 | 42858-067 | HUMAN PRESCRIPTION DRUG | Fenofibrate | Fenofibrate | CAPSULE | ORAL | 20170602 | N/A | ANDA | ANDA075753 | Rhodes Pharmaceuticals L.P. | FENOFIBRATE | 67 mg/1 | 100 CAPSULE in 1 BOTTLE (42858-067-01) |